Back to Search
Start Over
Endocrine disorders after heart transplantation: national cohort study.
- Source :
-
BMC Endocrine Disorders . 4/20/2020, Vol. 20 Issue 1, p1-10. 10p. 3 Charts, 1 Graph. - Publication Year :
- 2020
-
Abstract
- Background: Endocrine disorders in patients after heart transplantation (HT) remain understudied. We aimed to assess endocrine profiles and management of HT recipients in the early post- transplant period. Methods: We conducted a retrospective cohort study on 123 consecutive HT recipients in the Advanced Heart Failure and Transplantation Programme between 2009 and 2018. All recipients had per-protocol endocrine follow-up within the first postoperative year. The median time to first post-transplant endocrine follow-up was 3 months (IQR 2–4). We assessed the incidence of vitamin D deficiency, bone mineral density, history of low energy fractures, hypogonadism in male recipients, posttransplant diabetes mellitus, and thyroid and parathyroid function. Results: We enrolled 22 women and 101 men of median age 57 years (IQR 50–63). Post-transplant diabetes mellitus developed in 14 patients (11.4%). 18 of 25 patients (14.6%) with preexisting type 2 diabetes mellitus required intensification of antidiabetic therapy. 38 male patients (40.4%) had hypogonadism. 5 patients (4.6%) were hypothyroid and 10 (9.3%) latent hyperthyroid. Secondary hyperparathyroidism was present in 19 (17.3%), 25-hydroxyvitamin D deficiency in 64 (54.7%) of patients. Osteoporosis was present in 26 (21.1%), osteopenia in 59 (48.0%) patients. 47 vertebral fractures, 3 hip and 1 humerus fractures occurred in 21 patients. Most of the patients had coincidence of two or three disorders, while less than 5% did not have any endocrine irregularities. All patients received calcium and vitamin D supplements. Forty-six patients (37.4%) were treated with zoledronic acid, 12 (9.8%) with oral bisphosphonates. Two patients were treated with teriparatide. Conclusions: The prevalence of multiple endocrine disorders early after heart transplantation is high. Assessment and management of increased fracture risk and all other potentially affected endocrine axes should be considered as a standard of care in this early period. [ABSTRACT FROM AUTHOR]
- Subjects :
- *DIAGNOSIS of diabetes
*DIAGNOSIS of endocrine diseases
*HYPERTHYROIDISM diagnosis
*HYPOTHYROIDISM diagnosis
*THERAPEUTIC use of vitamin D
*DIETARY calcium
*DIABETES
*DIETARY supplements
*DIPHOSPHONATES
*ENDOCRINE diseases
*BONE fractures
*HEART transplantation
*HEART failure
*HYPERPARATHYROIDISM
*HYPOGLYCEMIC agents
*HYPOGONADISM
*LONGITUDINAL method
*MEDICAL protocols
*ORAL drug administration
*OSTEOPENIA
*OSTEOPOROSIS
*POSTOPERATIVE period
*SEX distribution
*SPINAL injuries
*TRANSPLANTATION of organs, tissues, etc.
*VITAMIN D deficiency
*HUMERUS injuries
*DISEASE management
*COMORBIDITY
*BONE density
*DISEASE incidence
*DISEASE prevalence
*RETROSPECTIVE studies
*ZOLEDRONIC acid
*TERIPARATIDE
Subjects
Details
- Language :
- English
- ISSN :
- 14726823
- Volume :
- 20
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- BMC Endocrine Disorders
- Publication Type :
- Academic Journal
- Accession number :
- 142814951
- Full Text :
- https://doi.org/10.1186/s12902-020-0533-6